Electroconvulsive Therapy for Catatonia in Autistic and Non‐Autistic Patients: An Observational Study on Course, Efficacy, Aggression, and Self‐Injury Outcomes
Open Access
- 8 September 2026
- journal article
- research article
- Published by Wiley in Autism Research
- p. e70362
Abstract
Catatonia occurs disproportionately in autistic individuals and may respond to electroconvulsive therapy (ECT), yet prior reports suggest greater treatment burden in this population. We compared longitudinal ECT utilization, safety, and clinical outcomes between autistic and non‐autistic patients with catatonia. This single‐center observational cohort included 110 patients treated from May 2022 through April 2026, comprising 43 autistic and 67 non‐autistic patients. Bush‐Francis Catatonia Rating Scale (BFCRS), Clinical Global Impression‐Improvement (CGI‐I), Clinical Global Impression‐Severity (CGI‐S), and Kanner Catatonia Severity and Examination scores were recorded across acute and maintenance treatment. Because the cohorts differed in age, biologic sex, and intellectual disability, treatment burden was evaluated using covariate‐adjusted, censoring‐aware models with a three‐level clinical‐group variable comprising non‐autism, autism with intellectual disability, and autism without intellectual disability. Autistic patients received more ECT sessions than non‐autistic patients (median, 35 vs. 14) over longer observed treatment courses (median, 342 vs. 97 days). After adjustment, this difference reflected longer retention in maintenance ECT rather than a higher treatment rate and was concentrated among autistic patients with intellectual disability (Cox hazard ratio, 0.21). Clinical improvement was observed in both cohorts: CGI‐I response occurred in 100.0% of autistic and 89.1% of non‐autistic patients, BFCRS reduction of at least 50% occurred in 76.9% and 75.4%, and CGI‐S improvement of at least 1 point occurred in 85.0% and 70.8%, respectively. Kanner total scores decreased significantly, and self‐injury prevalence declined from 42.9% to 17.1% among autistic patients. Combativeness improved in both cohorts, and documented adverse events were uncommon. ECT was associated with substantial clinical improvement in autistic and non‐autistic patients with catatonia. Autistic patients, particularly those with intellectual disability, experienced longer maintenance courses rather than more intensive treatment, underscoring the importance of sustained treatment access.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (1P50‐HD103537)
- National Institute of Mental Health (K23MH138987)
This publication has 57 references indexed in Scilit:
- Hospitalizations for pediatric catatonia in neurodivergent and neurotypical patientsGeneral Hospital Psychiatry, 2025
- Longitudinal Symptom Burden and Pharmacologic Management of Catatonia in Autism With Intellectual Disability: An Observational StudyAutism Research, 2025
- Deep Brain Stimulation of the Nucleus Accumbens for Severe Self-Injurious Behavior in Children: A Phase I Pilot TrialBiological Psychiatry, 2024
- Exploring the Heterogeneity of Self‐Injurious Behaviors in Autistic Youth: Patterns, Predictors, and Implications for InterventionAutism Research, 2024
- The Role of Parvalbumin Interneurons in Autism Spectrum DisorderJournal of Neuroscience Research, 2024
- Genetic syndromes are prevalent in patients with comorbid neurodevelopmental disorders and catatoniaAmerican Journal of Medical Genetics Part A, 2023
- Modulation of motor cortical excitability by continuous theta-burst stimulation in adults with autism spectrum disorderClinical Neurophysiology, 2021
- Catatonia in Children and Adolescents: A High Rate of Genetic ConditionsJournal of the American Academy of Child & Adolescent Psychiatry, 2018
- Modern Electroconvulsive TherapyJAMA Psychiatry, 2017
- Pharmacological intervention for irritability, aggression, and self-injury in Autism Spectrum Disorders (ASD)Cochrane Database of Systematic Reviews, 2015